Login  /  Register
AI in Healthcare, Tangible Benefits and Return on Investment
AI in Healthcare, Tangible Benefits and Return on Investment
Jan Sevcik   |  Jan 21, 2022
Where to begin for those delving into artificial intelligence in healthcare for the first time may be a bit of a conundrum, but Jan Sevcik shows organizations a path that provides tangible benefits and creates momentum.
More +
Transforming Women’s Healthcare With AI
Transforming Women’s Healthcare With AI
Priya Dialani   |  Jan 20, 2022
Priya Dialani believes women are being left behind as the Fourth Industrial Revolution gathers momentum, but has confidence, thanks to the advent of digitization, that digital health leaders can transform the landscape of women’s health by empowering women to take control of their wellbeing as well as supplanting commonly held misconceptions and taboos.
More +
Latest stories
The Yuan Presents Five Divinations for the New Year on ‘AI Eve’ 2021
Generic
The Yuan Presents Five Divinations for the New Year on ‘AI Eve’ 2021
After an almost apocalyptic year where the COVID-19 pandemic held the world to ransom, there is an AI light at the end of the tunnel. The Yuan Chief Editor Shifeng Wang laments the 2021 annus horribilis but predicts a better year ahead in 2022.
Shifeng Wang  |  Dec 24 , 2021
Should we be More Open to Sharing Medical Data for AI Development?
Domain Knowledge
Should we be More Open to Sharing Medical Data for AI Development?
Although many healthcare professionals understand that data sharing will offer opportunities to improve healthcare, these regulatory, ethical, and technological challenges prevent many institutions from sharing their data. Yet there are certain initiatives that offer opportunities to tackle these issues.
Martin Willemink  |  Dec 23 , 2021
China Leads World in AI Adoption Today
Emerging Market
China Leads World in AI Adoption Today
Effective, widespread artificial intelligence adoption is still a far-off scenario because of a massive talent shortage and limited AI expertise. John Kaller discusses the challenges of successfully adopting AI, how it can be achieved, and what a successful implementation can look like.
John Kaller  |  Dec 22 , 2021
Medical Image Recognition Sector’s Vision is Clearer
Domain Knowledge
Medical Image Recognition Sector’s Vision is Clearer
Medical image recognition is a deep, complex area, certainly in the early diagnosis of retinopathy. Anthropologist and AI expert Alec Balasescu shows how machine learning is helping to make the sector’s vision become much clearer.
Alec Balasescu  |  Dec 21 , 2021
AI Provides Key to Pandemic Preparedness
Pandemic
AI Provides Key to Pandemic Preparedness
The world appears to be on the cusp of monumental transformation in healthcare, thanks in no small part to COVID-19 which has provided a platform for the Fourth Industrial Revolution. Dr Gaurav Chandra believes this is an ideal opportunity for humanity to come together, work on tangible solutions to free us of this pandemic, prevent another, and leave a legacy for future generations.
Gaurav Chandra  |  Dec 20 , 2021
AI to Close US-China Gap in Mental Healthcare
Generic
AI to Close US-China Gap in Mental Healthcare
Dr Kaizhi Tang, co-founder, and Chief Technology Officer of Hangzhou Heaven Rock Technology, which operates the Soul Buddy mental health service platform app, shares his insights into how China’s artificial intelligence prowess, rising economic clout, and changing social attitudes are set to narrow the gulf between it and the United States in the mental healthcare arena.
Kaizhi Tang  |  Dec 17 , 2021
An AI Odyssey: Subverting Political Discourse or Healthcare Savior?
Optimization
An AI Odyssey: Subverting Political Discourse or Healthcare Savior?
The dynamic effects of artificial intelligence are already being felt in business, politics, medicine, and war, and dominate nearly every other domain of 21st century life. Joseph S. Nye reckons for all of AI’s positive potential, the technology presents significant risks that are best addressed sooner rather than later.
Joseph S. Nye  |  Dec 16 , 2021
Multimodal AI for Healthcare
Game-Changer
Multimodal AI for Healthcare
Multimodal artificial intelligence is the new kid on the AI block. It uses several data types, such as image, text, speech, and numerical data, and combines them with multiple intelligence processing algorithms to achieve higher performance. Data scientist and astrophysicist Dr Kirk Borne applies some context to multimodal AI’s ability to sense, understand, assimilate, synergize, and learn from multiple diverse inputs.
Kirk Borne  |  Dec 15 , 2021
Checkmate: The Future of AI Technology Makes a Move
New Era
Checkmate: The Future of AI Technology Makes a Move
On the 10th anniversary of artificial intelligence’s first successful applications, Satyen K. Bordoloi trawls through the history of computing and AI, explains the resistance to the technology in the past, and predicts that every company once hostile to AI will have embraced it in the next few years.
Satyen K. Bordoloi  |  Dec 14 , 2021
Pfizer Chief Maps Out Digital Strategy to Enlist AI in Drug Development
People
Pfizer Chief Maps Out Digital Strategy to Enlist AI in Drug Development
Nico Gariboldi, Site Lead of the Pfizer Center for Digital Innovation, talks to The Yuan about the activities, partnerships, and central role in implementing Pfizer’s digital strategy.
Eleni Natsi  |  Dec 13 , 2021
Community More+
Calum Chace
Calum Chace
Calum Chace is a keynote speaker and best-selling writer on AI. He focuses on the medium- and long-term impact of AI on all of us, our societies and our economies. He is the author of ‘Surviving AI,’ about strong AI and superintelligence.
Lenny Mendonca
Lenny Mendonca
Lenny Mendonca, Senior Partner Emeritus at McKinsey & Company, is a former chief economic and business adviser to Governor Gavin Newsom of California and chair of the California High-Speed Rail Authority.
Laura Tyson
Laura Tyson
Laura Tyson, former chair of the US President’s Council of Economic Advisers, is Professor of the Graduate School at the Haas School of Business and Chair of the Blum Center Board of Trustees at the University of California, Berkeley.
Emmanuel Fombu
Emmanuel Fombu
Emmanuel Fombu is a physician with a particular interest in the future of healthcare. Among his many accomplishments, he also holds a certification in AI: Implications for Business Strategy from MIT’s Sloan School of Management and Computer Science AI Lab.
Evelyne Bischof
Evelyne Bischof
Evelyne Bischof is chief physician associate of internal medicine at University Hospital Renji of Jiaotong University Shanghai and an executive at the Longevity Science Foundation. Her research focus is oncology and longevity medicine, AI and digital health, precision medicine, biogerontology and geronto-oncology.
Nicolas Ibanez
Nicolas Ibanez
Nicolas Ibanez is a physical therapist with a specialty in osteopathy and a passion for Digital Health Solutions. He has extensive experience in digital health solutions and is founder of Nuve, a health food franchise, EasyMD, a telehealth startup and Fisiomed, Nicaragua’s first sports medical clinic.
Reza Jarral
Reza Jarral
Reza Jarral is a physician, Edmund Hillary Fellow and a 'AI4Health' advisor at the World Health Organisation. Prior to joining CareHQ as the clinical director for virtual health, Reza worked alongside marginalised communities for over a decade, delivering care at the front line in the NHS, New Zealand and sub-Saharan Africa.
Verena Voelter
Verena Voelter
Verena Voelter is the founder and managing director of 5P Health Care Solutions, a consulting firm that supports the cocreation of innovative solutions for a modern value-based health care system. She is author of ‘It Takes 5 to Tango – From Competition to Cooperation in Health Care.’
Ikechukwu Enyeribe Anyanwu
Ikechukwu Enyeribe Anyanwu
Ikechukwu Enyeribe Anyanwu is a physician with over eight years of experience in clinical and hospital management. His interests span across global health management, healthcare quality improvement, digital health transformation and the strategic application of artificial intelligence in healthcare.
Gaurav Chandra
Gaurav Chandra
Gaurav Chandra is the Chief Operating Officer of Enzolytics, a drug development company. He also runs a platform that uses AI to assess the effects of nutrition, genetics and gut microbiome on chronic medical diseases and infectious diseases. He is a strong proponent of AI's role in early drug discovery and development.
Popular stories
Producing Healthy Food With AI
Producing Healthy Food With AI
Jan 11, 2022
AI Is Virus Antidote as Ireland Leverages Data
AI Is Virus Antidote as Ireland Leverages Data
Sep 16, 2021
Nano-Robotic Surgery Is the Future
Nano-Robotic Surgery Is the Future
Oct 29, 2021
AI Resource Management Clean Up Helps Deliver Better Healthcare
AI Resource Management Clean Up Helps Deliver Better Healthcare
Aug 27, 2021